About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.